secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0001104659-24-061200
Event type: debt
Sentiment:  negative
Materiality: 0.95
Item codes: 1.01, 2.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura gets $200K loan from controlling shareholder; warns bankruptcy possible if no new funds by early June
--------------------------------------------------------------------------------

- AD Pharma loaned $200K on May 10; total principal now $5.62M at 5.25%, due June 30, 2024.
- Accrued interest ~$310K; default rate rises to 7.5% after 5-day grace.
- Without additional financing by early June 2024, Acura may scale back operations or seek bankruptcy protection.
- AD Pharma directly owns ~65% of Acura common stock; Mr. Schutte (AD Pharma manager) owns ~13% directly.
- Loan proceeds used for day-to-day operations; no assurance further funding will be available.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465924061200/0001104659-24-061200-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465924061200/tm2414484d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-061200

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer